85 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
31 Jan 19
Notice of Extraordinary General Meeting of the Shareholders
4:59pm
(the “Meeting”), for the following purpose:
To appoint Yarel+Partners, Certified Public Accountants as the Company’s independent registered public … of Directors resolved to accept Enlivex’s request, and to convene an Extraordinary General Meeting of the Shareholders of the Company for the purpose
S-8
EX-5.1
ENLV
Enlivex Therapeutics Ltd
4 Jun 21
Registration of securities for employees
4:16pm
, as amended (the “Securities Act”), for the purpose of registering under the Securities Act 4,150,704 ordinary shares of the Company, par value NIS … express no opinion as to any laws other than the laws of the State of Israel as the same are in force on the date hereof and we have not, for purpose
F-3
ENLV
Enlivex Therapeutics Ltd
28 Jun 19
Shelf registration (foreign)
9:48am
of the other registered holders of the share and, for this purpose seniority shall be determined by the order in which the names stand in the shareholder … to be a single shareholder and may be deemed a controlling shareholder for the purpose of approving such transaction. Extraordinary transactions, including private
F-1/A
EX-3.2
ENLV
Enlivex Therapeutics Ltd
8 Jul 14
Registration statement (foreign) (amended)
12:00am
to the Company for the shares and which has not yet been paid.
Donations
The Company is entitled to donate a reasonable sum of money for a fit purpose … or securities that may be realized as shares up to the limit of the Company’s registered capital. For the purpose of calculating the limit
F-3
6y3zy2ck200qq9 r5ud
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
9m4rqa2svbp1 wy
19 Feb 19
Notice of Extraordinary General Meeting of the Shareholders
6:03am
6-K
EX-4.1
hhx8n 1k1h
5 Mar 20
Report of Foreign Private Issuer
8:16am
F-3
w0auvitbkx
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.2
0izvva1f4zf10
27 Mar 19
Securities Purchase Agreement
8:32am
424B3
65xcalf9ve z6j
10 Jul 19
Prospectus supplement
8:18am
6-K
EX-99.1
2rqxn7 5g1
23 Sep 14
Notice of Extraordinary General Meeting of Shareholders
12:00am
6-K
p1u64rk8hy2z
31 Dec 18
Current report (foreign)
4:05pm
6-K
EX-4.1
3uueaunt
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-5.1
g1w5h moqlhm
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm